Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

NCT06302660 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06302660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Active, not recruiting
Start date
March 9, 2022
Completion date
December 1, 2025
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial overgrowth, oesophageal cancer, quality of life